ASP Isotopes' Quantum Leap Energy Unit Commences Early Engagement For Regulatory Pathways With UK's Regulators To Produce High-Assay Low Enriched Uranium In UK

ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of isotopes for multiple industries, today announced a regulatory progress update in its initiative to produce High-Assay Low Enriched Uranium ("HALEU") in the United Kingdom. The Company's UK subsidiary, Quantum Leap Energy Ltd ("QLE Ltd"), has formally commenced early engagement for regulatory pathways ("Early Engagement") with the UK's regulators on new nuclear projects.